|
|
Post by peppy on Jan 31, 2021 9:41:01 GMT -5
180 Wealth Advisors LLC raised its holdings in MannKind Co. (NASDAQ:MNKD) by 23.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 619,025 shares of the biopharmaceutical company’s stock after buying an additional 119,533 shares during the period. 180 Wealth Advisors LLC owned about 0.27% of MannKind worth $1,987,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds and other institutional investors have also modified their holdings of MNKD. Two Sigma Advisers LP bought a new position in shares of MannKind in the second quarter valued at approximately $216,000. Virtu Financial LLC purchased a new stake in MannKind in the 3rd quarter valued at $77,000. JPMorgan Chase & Co. lifted its stake in MannKind by 13.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 82,121 shares of the biopharmaceutical company’s stock valued at $157,000 after acquiring an additional 10,043 shares in the last quarter. Kestra Private Wealth Services LLC purchased a new position in MannKind during the 4th quarter worth $60,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of MannKind by 6.9% in the 2nd quarter. Goldman Sachs Group Inc. now owns 287,657 shares of the biopharmaceutical company’s stock worth $503,000 after acquiring an additional 18,473 shares in the last quarter. Hedge funds and other institutional investors own 29.60% of the company’s stock.
|
|
|
|
Post by goyocafe on Jan 31, 2021 9:56:20 GMT -5
180 Wealth Advisors LLC raised its holdings in MannKind Co. (NASDAQ:MNKD) by 23.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 619,025 shares of the biopharmaceutical company’s stock after buying an additional 119,533 shares during the period. 180 Wealth Advisors LLC owned about 0.27% of MannKind worth $1,987,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds and other institutional investors have also modified their holdings of MNKD. Two Sigma Advisers LP bought a new position in shares of MannKind in the second quarter valued at approximately $216,000. Virtu Financial LLC purchased a new stake in MannKind in the 3rd quarter valued at $77,000. JPMorgan Chase & Co. lifted its stake in MannKind by 13.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 82,121 shares of the biopharmaceutical company’s stock valued at $157,000 after acquiring an additional 10,043 shares in the last quarter. Kestra Private Wealth Services LLC purchased a new position in MannKind during the 4th quarter worth $60,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of MannKind by 6.9% in the 2nd quarter. Goldman Sachs Group Inc. now owns 287,657 shares of the biopharmaceutical company’s stock worth $503,000 after acquiring an additional 18,473 shares in the last quarter. Hedge funds and other institutional investors own 29.60% of the company’s stock.
So are the hedge funds tossing shares back and forth between short and long positions and keeping the share price in check. Create some momentum and sell short into it, and cover two days later by creating more momentum? I wouldn’t put it past them. |
|
|
|
Post by peppy on Jan 31, 2021 10:14:21 GMT -5
180 Wealth Advisors LLC raised its holdings in MannKind Co. (NASDAQ:MNKD) by 23.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 619,025 shares of the biopharmaceutical company’s stock after buying an additional 119,533 shares during the period. 180 Wealth Advisors LLC owned about 0.27% of MannKind worth $1,987,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds and other institutional investors have also modified their holdings of MNKD. Two Sigma Advisers LP bought a new position in shares of MannKind in the second quarter valued at approximately $216,000. Virtu Financial LLC purchased a new stake in MannKind in the 3rd quarter valued at $77,000. JPMorgan Chase & Co. lifted its stake in MannKind by 13.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 82,121 shares of the biopharmaceutical company’s stock valued at $157,000 after acquiring an additional 10,043 shares in the last quarter. Kestra Private Wealth Services LLC purchased a new position in MannKind during the 4th quarter worth $60,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of MannKind by 6.9% in the 2nd quarter. Goldman Sachs Group Inc. now owns 287,657 shares of the biopharmaceutical company’s stock worth $503,000 after acquiring an additional 18,473 shares in the last quarter. Hedge funds and other institutional investors own 29.60% of the company’s stock.
So are the hedge funds tossing shares back and forth between short and long positions and keeping the share price in check. Create some momentum and sell short into it, and cover two days later by creating more momentum? I wouldn’t put it past them. What choice did they have? They had to lie to as all for years to kill us. After all, who wants a nice stable blood glucose level? When they have a license to kill.   Burnin in my soul It's outta control  |
|
|
|
Post by mytakeonit on Jan 31, 2021 15:42:54 GMT -5
It seems like 29.60% of MNKD is a lot more shares than stated in that article. Heck, I have more shares than what I see above.
But, that's mytakeonit
|
|
|
|
Post by mytakeonit on Jan 31, 2021 15:54:11 GMT -5
Here is the current institutional holdings.
institutional shareholder concentration
Value ($MM) % O/S Shares
Top 10 Inst. 99.33 24.20 57,030,590
Top 20 Inst. 113.89 27.13 63,937,060
Top 50 Inst. 131.71 30.76 72,499,472
Total Inst. 141.36 32.83 77,371,054
|
|
